Showing 1407 results
-
Story /Two Novartis leaders share their perspectives on digital health in 2020 – and the key trends to watch out for over the next 12 months.
-
Press release /Entresto reversed trend of worsening New York Heart Association (NYHA) class - a key measure of the severity of a patient's heart failure symptoms - improving common…
-
Press release /Detailed results from Phase II study in chronic migraine prevention showed patients on AMG 334 (erenumab) were significantly more likely to experience a 50% or more reduction in monthly migraine…
-
Ad hoc release /PARAGON study narrowly misses statistical significance on the primary endpoint; overall safety profile confirmed Totality of evidence suggests potential clinically important benefit; results will…
-
Press release /Results from year two of the pivotal Phase III KITE clinical trial reaffirmed visual acuity gains and fluid reduction findings as well as safety profile from year one1,2 In key fluid-related…
-
Press release /Der Nettoumsatz steigt um 1% (kWk[1]), da die Wachstumsprodukte die Einbussen bei Gleevec kompensieren Die Wachstumsprodukte[2] steigern den Umsatz um 24% (USD) auf USD 3,9 Milliarden bzw. 34%…
-
Story /The Chief Information Officer of the Novartis Institutes for BioMedical Research discusses his new role.
-
Story /One man’s fascination with malaria helps fuel the search for new treatments.
-
Story /Ambitious scientist accelerates research into African genomic diversity and health challenges with internship
-
Story /For over 60 years Novartis has been committed to helping people with cardiovascular disease and we remain steadfast in that commitment to this day.